Role of Microenvironment on the Fate of Disseminating Cancer Stem Cells.

agents targeting microenvironment cancer stem cells dormancy metastatic niche microenvironment

Journal

Frontiers in oncology
ISSN: 2234-943X
Titre abrégé: Front Oncol
Pays: Switzerland
ID NLM: 101568867

Informations de publication

Date de publication:
2019
Historique:
received: 23 11 2018
accepted: 29 01 2019
entrez: 9 3 2019
pubmed: 9 3 2019
medline: 9 3 2019
Statut: epublish

Résumé

Disseminating Cancer Stem Cells (CSCs) initiate growth in specific niches of the host tissues, the cellular and molecular components of which sustain signaling pathways that support their survival, self-renewal dormancy and reactivation. In the metastatic niche, tumor cells may enter in a dormant state to survive and, consequently, the metastasis can remain latent for years. Despite the clinical importance of metastatic latency, little is known about what induces CSCs to enter a dormant state and what allows them to remain viable for years in this state. CSCs exhibit genetic, epigenetic and cellular adaptations that confer resistance to classical therapeutic approaches. The identification of potential CSC targets is complicated by the fact that CSCs may arise as a consequence of their relationship with the local microenvironment into the metastatic niches. Indeed, microenvironment modulates the capability of CSCs to evade the innate immune response and survive. Some new therapeutic options that include drugs targeting microenvironment components are achieving encouraging results in reducing the number of CSCs in tumors and/or overcoming their resistance in preclinical studies. This review will focus on specific CSC features with an emphasis on the role of tumor microenvironment in supporting metastatic dissemination of CSCs. In addition, it sheds light on potential microenvironment-targeted therapies aimed to counteract seeding and survival of CSCs in the metastatic niche.

Identifiants

pubmed: 30847298
doi: 10.3389/fonc.2019.00082
pmc: PMC6393337
doi:

Types de publication

Journal Article Review

Langues

eng

Pagination

82

Références

J Cell Biol. 1999 Oct 4;147(1):89-104
pubmed: 10508858
Cancer Res. 2000 May 1;60(9):2541-6
pubmed: 10811137
Mol Biol Cell. 2001 Apr;12(4):863-79
pubmed: 11294892
J Leukoc Biol. 2001 Apr;69(4):522-30
pubmed: 11310837
Nature. 2001 Nov 1;414(6859):105-11
pubmed: 11689955
Nat Rev Cancer. 2002 Aug;2(8):563-72
pubmed: 12154349
Nat Med. 2004 Feb;10(2):145-7
pubmed: 14745444
Nat Rev Cancer. 2004 Jun;4(6):448-56
pubmed: 15170447
Nat Med. 2004 Sep;10(9):942-9
pubmed: 15322536
Nature. 2005 Dec 8;438(7069):820-7
pubmed: 16341007
J Natl Cancer Inst. 2006 Mar 1;98(5):316-25
pubmed: 16507828
Proc Natl Acad Sci U S A. 2006 Mar 14;103(11):4216-21
pubmed: 16537511
J Exp Med. 2006 Apr 17;203(4):871-81
pubmed: 16606666
Am J Pathol. 2006 Aug;169(2):673-81
pubmed: 16877365
Nature. 2007 Sep 27;449(7161):419-26
pubmed: 17898760
Cell. 2008 Jul 25;134(2):215-30
pubmed: 18662538
Cancer Cell. 2009 Jan 6;15(1):35-44
pubmed: 19111879
Nat Rev Cancer. 2009 Apr;9(4):239-52
pubmed: 19279573
J Exp Med. 2009 Jun 8;206(6):1327-37
pubmed: 19451266
Cancer Cell. 2009 Jul 7;16(1):67-78
pubmed: 19573813
Cancer Res. 2010 Jan 15;70(2):697-708
pubmed: 20068175
J Eur Acad Dermatol Venereol. 2010 Jul;24(7):833-6
pubmed: 20070457
Nat Rev Cancer. 2010 Feb;10(2):138-46
pubmed: 20094048
J Clin Invest. 2010 Jun;120(6):2030-9
pubmed: 20501944
Proc Natl Acad Sci U S A. 2010 Oct 19;107(42):18115-20
pubmed: 20921380
Cell. 2011 Mar 4;144(5):646-74
pubmed: 21376230
Nat Rev Cancer. 2011 Jun 24;11(7):512-22
pubmed: 21701513
Clin Cancer Res. 2012 Jan 15;18(2):408-16
pubmed: 22038994
J Exp Med. 2011 Dec 19;208(13):2641-55
pubmed: 22124112
Nature. 2011 Dec 07;481(7379):85-9
pubmed: 22158103
J Mol Med (Berl). 2012 Jul;90(7):803-15
pubmed: 22231744
Cell. 2012 Feb 3;148(3):399-408
pubmed: 22304911
Proc Natl Acad Sci U S A. 2012 Feb 21;109(8):2784-9
pubmed: 22308314
J Exp Med. 2012 Mar 12;209(3):495-506
pubmed: 22351930
Cancer Metastasis Rev. 2012 Dec;31(3-4):429-40
pubmed: 22699312
Cancer Discov. 2012 Sep;2(9):840-55
pubmed: 22763855
J Cell Biol. 2012 Aug 6;198(3):281-93
pubmed: 22869594
Cell. 2012 Aug 17;150(4):764-79
pubmed: 22901808
Cancer Discov. 2012 Sep;2(9):775-7
pubmed: 22969117
Am J Pathol. 2012 Nov;181(5):1573-84
pubmed: 23022210
Cancer Res. 2013 Mar 1;73(5):1524-35
pubmed: 23288510
J Immunol. 2013 Mar 1;190(5):2381-90
pubmed: 23345327
Cancer Cell. 2013 Feb 11;23(2):171-85
pubmed: 23375636
Clin Cancer Res. 2013 Jul 1;19(13):3567-76
pubmed: 23695169
PLoS One. 2013 Aug 29;8(8):e72962
pubmed: 24009721
Cell Cycle. 2013 Nov 15;12(22):3526-36
pubmed: 24091630
Nat Cell Biol. 2013 Nov;15(11):1351-61
pubmed: 24161934
Cancer Microenviron. 2014 Aug;7(1-2):41-59
pubmed: 24424657
Cell Stem Cell. 2014 Mar 6;14(3):306-21
pubmed: 24607405
Cancer Cell. 2014 May 12;25(5):590-604
pubmed: 24794706
Nat Rev Cancer. 2014 Jun;14(6):430-9
pubmed: 24827502
Nat Cell Biol. 2014 Aug;16(8):717-27
pubmed: 25082194
Nat Rev Cancer. 2014 Sep;14(9):611-22
pubmed: 25118602
Cancer Res. 2014 Dec 1;74(23):6745-9
pubmed: 25411346
Nat Rev Immunol. 2015 Feb;15(2):73-86
pubmed: 25614318
Cancer Res. 2015 Mar 15;75(6):996-1008
pubmed: 25623234
Matrix Biol. 2015 May-Jul;44-46:200-6
pubmed: 25652204
Nature. 2015 Jun 18;522(7556):345-348
pubmed: 25822788
J Immunol. 2015 Jun 1;194(11):5529-38
pubmed: 25911761
Nat Cell Biol. 2015 Jun;17(6):816-26
pubmed: 25985394
Connect Tissue Res. 2015;56(5):414-25
pubmed: 26291921
Cell Adh Migr. 2015;9(5):345-56
pubmed: 26312653
Lancet. 2015 Feb 26;385 Suppl 1:S59
pubmed: 26312881
Oncoimmunology. 2015 Apr 2;4(9):e1027472
pubmed: 26405598
Front Oncol. 2015 Oct 20;5:224
pubmed: 26539408
Nature. 2015 Dec 17;528(7582):413-7
pubmed: 26649828
J Mol Med (Berl). 2016 May;94(5):509-22
pubmed: 26689709
Cancer Res. 2016 Mar 15;76(6):1335-47
pubmed: 26719537
Cancer Res. 2016 Mar 15;76(6):1381-90
pubmed: 26719539
Cell. 2016 Mar 24;165(1):45-60
pubmed: 27015306
Am J Physiol Cell Physiol. 2016 Jun 1;310(11):C955-67
pubmed: 27053524
Sci Transl Med. 2016 May 25;8(340):340ra73
pubmed: 27225183
Bioessays. 2016 Jul;38 Suppl 1:S65-74
pubmed: 27417124
Cancer Cell. 2016 Aug 8;30(2):243-256
pubmed: 27505671
Cancer Cell. 2016 Nov 14;30(5):668-681
pubmed: 27846389
J Stem Cell Res Ther. 2016 Oct;6(10):
pubmed: 27891292
Nat Commun. 2016 Dec 23;7:13720
pubmed: 28008905
Mol Cancer. 2017 Feb 1;16(1):29
pubmed: 28148257
Cancer Cell. 2017 Mar 13;31(3):355-367
pubmed: 28238683
Mol Oncol. 2017 Aug;11(8):1023-1034
pubmed: 28453235
Biochim Biophys Acta Rev Cancer. 2017 Aug;1868(1):231-238
pubmed: 28501561
Cancer Res. 2017 Aug 1;77(15):4158-4170
pubmed: 28611041
Trends Cancer. 2017 May;3(5):372-386
pubmed: 28718414
Trends Cancer. 2016 Jun;2(6):295-304
pubmed: 28741527
Oncotarget. 2017 Jun 12;8(34):56126-56142
pubmed: 28915578
Sci Rep. 2018 Jan 8;8(1):40
pubmed: 29311669
Cell. 2018 Feb 8;172(4):841-856.e16
pubmed: 29395328
Cancer Res. 2018 Jun 1;78(11):2911-2924
pubmed: 29514796
Nat Rev Cancer. 2018 Nov;18(11):669-680
pubmed: 30228301
Cancer Discov. 2019 Jan;9(1):96-113
pubmed: 30361447
Nat Commun. 2018 Dec 19;9(1):5395
pubmed: 30568162
J Natl Cancer Inst. 1999 Jan 6;91(1):80-5
pubmed: 9890174

Auteurs

Vincenzo Ingangi (V)

IRCCS Istituto Nazionale Tumori, Fondazione G. Pascale, Naples, Italy.

Michele Minopoli (M)

IRCCS Istituto Nazionale Tumori, Fondazione G. Pascale, Naples, Italy.

Concetta Ragone (C)

Department of Experimental Medicine, University of Campania Luigi Vanvitelli, Naples, Italy.

Maria Letizia Motti (ML)

IRCCS Istituto Nazionale Tumori, Fondazione G. Pascale, Naples, Italy.
Department of Sport Science and Wellness, University Parthenope, Naples, Italy.

Maria Vincenza Carriero (MV)

IRCCS Istituto Nazionale Tumori, Fondazione G. Pascale, Naples, Italy.

Classifications MeSH